+3.37% for UiPath stock as Deloitte partnership expands enterprise test adoption

Traders Union
All News
Financial News
UiPath jumps 3.37% today to $11.97

Highlights

UiPath achieved its first GAAP profitability with $28 million operating income on 17.3% revenue growth, signaling accelerated business momentum.
Strategic expansion into agentic AI for regulated industries and a Deloitte partnership strengthens enterprise automation positioning and future growth potential.
Shares trade above key short-term levels but overbought conditions and weak trend signals suggest likely consolidation between $11.50 and $12.30 in the near term.

Operational gains and new AI moves drive investor optimism

UiPath’s fiscal first quarter 2027 results demonstrate accelerating business momentum, with revenue rising 17.3% year-over-year to $418.4 million and the company achieving GAAP profitability for the first time with an operating income of $28 million. This marked improvement in financial performance has spurred renewed investor interest by confirming both top-line growth and operational execution. Additional upside is supported by UiPath’s launch of new coding agent integrations and its expansion into agentic AI solutions for government and regulated industries, as well as the announced partnership with Deloitte aimed at driving adoption of automation in enterprise software testing.

Uptrend challenged by resistance and overbought momentum signals

For PATH, the price is currently testing today’s high of $12.00, having rebounded sharply from a downside gap at the open. Notably, price action is above both the SMA-20 ($10.60) and SMA-50 ($10.73), but remains under longer-term resistance at the SMA-200 ($12.99). The Ichimoku Kijun level at $10.64 provides immediate support. Momentum signals are mixed — MACD indicates renewed buying while ADX on daily and weekly charts suggests weak trend conviction. Overbought readings in RSI (62), CCI (196), and a fully maxed Stoch RSI (100) highlight stretched short-term conditions. BBP at 1.27 underscores strong intraday buyer dominance, and the Awesome Oscillator supports the emerging uptrend amid elevated volatility.

Consolidation likely as technical overextension tempers breakout risk

Looking ahead to the next five trading days, PATH is likely to oscillate between $11.50 and $12.30, reflecting a typical volatility band relative to current levels. Overbought technical conditions and weak medium-term trend signals imply that sideways consolidation or a mild pullback is significantly more probable than a sustained breakout. A bullish scenario would require a close and hold above $12.30 to challenge the longer-term resistance set by the SMA-200, while a bearish outcome could materialize if support at $11.50 is breached, potentially shifting momentum lower in line with recent weekly signals.

Viktoras Karapetjanc, expert at Traders Union, believes UiPath’s notable jump in both revenue and first-time GAAP profitability signals a major improvement in operational strength. He sees the new AI initiatives and Deloitte partnership as strong drivers for institutional demand and future growth, reinforcing current investor optimism. Technical signals may favor sideways action near $12.00 for now, but the overall outlook remains positive. "With UiPath building momentum on both the financial and innovation fronts, I expect institutional interest to keep supporting the stock as long as growth execution stays on track."

Earlier, analysts noted that UiPath was exhibiting bullish momentum amid new AI integrations and strengthening investor sentiment, though warned of mounting overbought signals. With recent confirmation of GAAP profitability and continued upside price action, attention now shifts to the sustainability of current gains, with $12.30 emerging as a pivotal level for a potential breakout or consolidation.

Source of Data: PATH Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.